empagliflozin
Showing 1 - 3 of 3
Glucose Metabolism Disorders, Diabetes, Type 2, Hypoglycemic Agents Trial in Karachi (Empagliflozin 10 MG,
Recruiting
- Glucose Metabolism Disorders
- +3 more
- Empagliflozin 10 MG
- Insulin+Metformin+DPP4 inhibitor (DPP4I)
-
Karachi, PakistanSINA Shireen Jinnah colony
Nov 28, 2023
Chronic Hepatitis b, NAFLD, Cirrhosis Trial in Hong Kong (Empagliflozin 10 MG, Placebo pills)
Recruiting
- Chronic Hepatitis b
- +5 more
- Empagliflozin 10 MG
- Placebo pills
-
Hong Kong, Hong Kong, China, Hong KongThe University of Hong Kong/Queen Mary Hospital
May 31, 2022
Kidney Transplantation, Metabolic Disorder, Metformin Trial (SGLT2 inhibitor, Metformin, Placebo)
Not yet recruiting
- Kidney Transplantation
- +3 more
- SGLT2 inhibitor
- +2 more
- (no location specified)
Aug 13, 2021